Scientists showed that butyrophilin 2A1 (BTN2A1) was required for BTN3A-mediated Vγ9Vδ2 T cell cytotoxicity against cancer cells, and that expression of the BTN2A1/BTN3A1 complex was sufficient to trigger Vγ9Vδ2 TCR activation.
[Cell Reports]
6445218
{6445218:MMIFVS3N}
apa
50
1
164491
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
